icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
Cmfze9Je1YwYdwMh
Listen
